Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

The IgG-based biotherapeutic agents that have ... Following the success of the first generation of monoclonal antibody blockbusters, second-generation antibodies were recently approved.

Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...

“Monoclonal antibodies are our core competence,” said ... “ADLib is a robust and simple method incorporating selection, full-length IgG expression, de novo humanisation, and affinity ...

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in ...

This phenomenon prolongs IgG circulation time and antibody response ... believes that acid-switched monoclonal antibodies show considerable promise for improving snakebite therapy. “They have ...

This important study explores the conserved role of IgM in both systemic and mucosal antiviral immunity in teleosts, challenging established views on the differential roles of IgT and IgM. The ...